Search

Your search keyword '"Brenton, JD"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Brenton, JD" Remove constraint Author: "Brenton, JD" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
39 results on '"Brenton, JD"'

Search Results

1. Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.

2. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

3. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

4. Profiling the immune landscape in mucinous ovarian carcinoma

5. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

6. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

7. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

8. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

9. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

10. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

11. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

12. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

13. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8(+) TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas

14. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

15. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

16. Prognostic gene expression signature for high-grade serous ovarian cancer

17. Shared heritability and functional enrichment across six solid cancers

18. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

19. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

20. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

21. Shared heritability and functional enrichment across six solid cancers.

22. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

23. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

24. Copy number signatures and mutational processes in ovarian carcinoma

25. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

26. Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients

27. Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

28. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

29. Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes

30. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

31. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer

32. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

33. Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes

34. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

35. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

36. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

37. High resolution melting for mutation scanning of TP53 exons 5-8

38. MMASS: an optimized array-based method for assessing CpG island methylation.

39. Differential expression of selected histone modifier genes in human solid cancers

Catalog

Books, media, physical & digital resources